[Please upgrade your browser to play this video content]
The Society of Critical Care Medicine's Critical Care Congress features internationally renowned faculty and content sessions highlighting the most up-to-date, evidence-based developments in critical care medicine. This is a presentation from the 2020 Critical Care Congress held February 16-19, 2020, in Orlando, Florida, USA.
This program is supported by an educational grant from Merck & Co., Inc.
Learning Objectives
Welcome and Introductions
Marin H. Kollef
HABP and VABP: Epidemiology, Microbiology, and Clinical Consequences
Richard Wunderink
Considerations for Antiobiotic Therapy for MDR Infections in HABP and VABP
Debra Goff
New and Emerging Therapies: A Closer Look at the Data
Individualizing Therapy to Support Antimicrobial Stewardship and Improved Outcomes
Marin Kollef
Concluding Remarks and Audience Q&A